A U.K. court invalidated Eli Lilly & Co.'s formulation patent relating to the Cialis erectile dysfunction drug but warned a group of generic drug manufacturers that they would be infringing another Cialis-related patent if they launch their products before that patent expires (Actavis Group PTC EHF v. ICOS Carp. [2016] EWHC 1955 (Pat) (UK)).
展开▼
机译：英国一家法院将礼来公司与Cialis勃起功能障碍药物有关的配方专利作废，但警告一群仿制药制造商，如果他们在该专利到期之前投放产品，将侵犯另一项与Cialis相关的专利（Actavis Group PTC EHF诉ICOS Carp。[2016] EWHC 1955（Pat）（UK））。
展开▼
